Crohn's Disease and Colitis Trial, Recruiting NCT04946448 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT04946448
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You have active inflammation in the lower part of your small intestine and/or colon, confirmed by a camera test (colonoscopy) showing a score above a certain level
  • You have been experiencing frequent bowel movements and abdominal pain at a level above a certain threshold, based on your own reported symptoms over 7 days
  • A stool test shows a high level of a protein called calprotectin (above 250 µg/g), which indicates active inflammation in the gut

Who may not be able to join:

  • You currently have an abscess (a pocket of infection) in your bowel
  • You have had part of your bowel surgically removed within the last 6 months
  • You have a stoma (an opening in the abdomen where waste is collected in a bag)
  • You have short-bowel syndrome (a condition where not enough of the small intestine is working properly)
  • You have a significant narrowing of the bowel that doctors think may need surgery
  • You are currently pregnant
  • You are currently breastfeeding, or you are planning to become pregnant during the study
  • You are unwilling or unable to follow the specific diet required by the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: João PG Sabino, MD PhD, UZ Leuven

Phone: 003216341770

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 September 2021
Est. completion
30 September 2025

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Steroid-free clinical and biochemical remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov